Showing results (21-30 of 2,405) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 8, 2011
Cost effectiveness of zoledronic acid in the management of skeletal metastases in hormone-refractory prostate cancer patients in France, Germany, Portugal, and the NetherlandsJ A Carter, A Joshi, S Kaura, et al.Journal of Medical Economics|April 11, 2019
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and ItalyEvangelos Terpos, Aurelien Jamotte, Alexandra Christodoulopoulou, et al.Journal of Medical Economics|April 11, 2019
Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillationJean-Baptiste Briere, Kevin Bowrin, Aurélie Millier, et al.Journal of Medical Economics|June 5, 2019
Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI)Louis S Matza, John E Brazier, Katie D Stewart, et al.Journal of Medical Economics|June 26, 2019
Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarkerMauricio A Berdugo, Noam Y Kirson, Louise Zimmer, et al.Journal of Medical Economics|June 26, 2019
Real-world healthcare resource utilization related to migraine treatment failure: a panel-based chart review in France, Germany, Italy, and SpainPamela Vo, Wei Gao, Miriam L Zichlin, et al.Journal of Medical Economics|July 22, 2016
Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancerAna Clopes, Montse Gasol, Rosana Cajal, et al.Journal of Medical Economics|April 24, 2015
A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health ServiceKirsten Westerhout, Maarten Treur, Angelika Mehnert, et al.Journal of Medical Economics|April 23, 2015
A selective review of the first 20 years of instrumental variables models in health-services research and medicineJohn CawleyJournal of Medical Economics|June 30, 2015
Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorderAbhishek Chitnis, Rosa Wang, Shawn X Sun, et al.Pageof 241